The Discounted Cash Flow (DCF) valuation of Essex Bio-Technology Ltd (1061.HK) is 7.15 HKD. With the latest stock price at 4.60 HKD, the upside of Essex Bio-Technology Ltd based on DCF is 55.4%.
Based on the latest price of 4.60 HKD and our DCF valuation, Essex Bio-Technology Ltd (1061.HK) is a buy. buying 1061.HK stocks now will result in a potential gain of 55.4%.
| Range | Selected | |
| WACC / Discount Rate | 8.2% - 12.1% | 10.1% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 5.81 - 9.41 | 7.15 |
| Upside | 26.2% - 104.6% | 55.4% |